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Summary
Telomeres are specialized DNA-protein structures at the
ends of eukaryotic chromosomes. Telomeric DNA is synthe-
sized by telomerase, which is expressed only at the early
stages of development [1, 2]. To become malignant, any
cell has to be able to replenish telomeres [3]. Thus, under-
standing how telomere length is monitored has significant
medical implications, especially in the fields of aging and
cancer. In yeast, telomerase is constitutively active. A large
network of genes participates in controlling telomere length
[4–8]. Tor1 and Tor2 (targets of rapamycin [9]) are two
similar kinases that regulate cell growth [10]. Both can be
found as part of the TOR complex 1 (TORC1 [11]), which
coordinates the response to nutrient starvation and is sensi-
tive to rapamycin [12]. The rapamycin-insensitive TOR com-
plex 2 (TORC2) contains only Tor2 and regulates actin cyto-
skeleton polarization [13]. Here we provide evidence for
a role of TORC1 in telomere shortening upon starvation in
yeast cells. The TORC1 signal is transduced by the Gln3/
Gat1/Ure2 pathway, which controls the levels of the Ku het-
erodimer, a telomere regulator. We discuss the potential
implications for the usage of rapamycin as a therapeutic
agent against cancer and the effect that calorie restriction
may have on telomere length.Results
To test a possible role of the target of rapamycin (TOR)
pathway in telomere length maintenance, we grew different
wild-type strains for 100 generations either in rich medium,
rich medium containing sublethal concentrations of rapamy-
cin, low-glucose medium, or low-nitrogen medium. As seen
in Figure 1, both nutrient shortage and rapamycin lead to telo-
mere shortening. Because rapamycin must interact with Fpr1
in order to inhibit TOR kinase activity [14, 15], we monitored
telomere length in strains deleted for the FPR1 gene. If indeed
rapamycin shortens telomere by inhibiting TOR kinase activity,
then Dfpr1mutants should be resistant to telomere shortening
by rapamycin (RTSR), but not resistant to telomere shortening
caused by low nutrient availability. Reassuringly, Dfpr1 strains
(which have elongated telomeres, probably related to the role
of Fpr1 in chromatin maintenance) are resistant to the effect of
rapamycin and sensitive to the effect of nitrogen shortage on
telomere length (Figure 1D). The rapamycin-Fpr1 complex3These authors contributed equally to this work
*Correspondence: martin@post.tau.ac.ilinhibits TOR complex 1 (TORC1), but not TORC2 [11]. Hence,
the telomere shortening observed is likely the result of inhibi-
tion of a TORC1-dependent function. Further analysis showed
that Tor2 is the kinase that transmits the starvation signal to
the telomeres (see Figure S1A available online).
We checked the effect of rapamycin on telomere length in 30
strains, each deleted for a different component of the TOR
signaling pathway (Table S1). We found that deletion of
FPR1,GAT1, andDAL80 causes telomere elongation, whereas
in the absence of TOR2 (but not TOR1), KOG1, TCO89, GLN3,
TAP42, and TIF4631 telomeres shorten (Figure S1B; data not
shown). The telomeres ofmostmutants of the TORC1 complex
were not further affected by rapamycin (RTSR phenotype; Fig-
ure S1B; data not shown). These results support the notion
that TORC1 plays a role in the control of telomere length in
response to nutrient availability.
TORC1 has a central role in the response to starvation,
controlling—among other pathways—autophagy [16], piece-
meal autophagy of the nucleus [17], and translation initiation
[18]. However, mutants defective in these processes (Datg1,
Datg5, Datg6, Datg7, Dpep4, Dnvj1, and Dsui2) were still able
to respond to rapamycin, shortening their telomeres (Fig-
ure S1C). Upon nitrogen starvation, the Gln3 and Gat1 tran-
scription factors (TFs) enter the nucleus and promote tran-
scription from a battery of nitrogen catabolite repression
(NCR) genes, such as DAL4, GLN1, and PUT1 [19–21]. As
long as nutrients are available, the activity of TORC1 prevents
the TFs from entering the nucleus: they are kept in a phosphor-
ylated form. Inhibition of TORC1 by the absence of nitrogen
(mimicked by rapamycin) leads to the dephosphorylation of
Gln3 and Gat1, their dissociation from the cytoplasmatic
Ure2p and their import to the nucleus, where they promote
gene expression [19, 20]. Interestingly, mutants defective
for the two TFs or their upstream regulators Tap42, Sit4,
Pph21/22, and Ure2 show abnormal telomere length (Figure 2;
Table S1; Figures S1B and S1C). It is still unclear why gln3
mutants exhibit short telomeres, whereas cells lacking Gat1
have abnormally long telomere length. Similar discrepancies
in the phenotypes of the two mutants have been previously re-
ported for nitrogen starvation [21, 22]. Compensatory activities
by these alternative transcription factors may account for the
differences; indeed, the double mutant gln3 gat1 exhibits telo-
meres of normal length. Additional evidence for different roles
for Gat1 and Gln3 comes from the sensitivity of the various
mutants to low levels of rapamycin (Figure 2C): whereas gln3
mutants display increased resistance to rapamycin, gat1
shows only a slightly increased resistance to the drug,
implying that the sensitivity of the wild-type strains is mainly
due to the activity of Gln3. The finding that ure2 exhibits an
RTSR phenotype (Figure 2) suggests that telomeres are regu-
lated similarly to NCR genes: deletion of each TF does not
impair the response (telomere shortening), whereas lack of
both factors (or the triple ure2 gln3 gat1 mutant) shows
RTSR phenotype (Figure 2).
What is the mechanism by which rapamycin affects telo-
mere length? We took advantage of the fact that many telo-
mere- length maintenance (TLM) genes have been identified
in yeast [4–6] in order to search for those that participate in
Figure 1. Telomere Southern Blots
Strains were grown for 100 generations on YPD, YPD
containing rapamycin, low-glucose medium, or low-
nitrogen medium. DNA was digested with XhoI and
probed with telomere sequences and with unique
genomic sequences used as markers. A dotted line
marks the size of the wild-type (WT) telomeres.
(A) Kinetics of rapamycin-induced telomere shortening.
TheWT strain was streaked on YPD containing 30 nM ra-
pamycin plates for five streaks. Every streak represents
approximately 25 generations. At this concentration,
cell growth was extremely slow.
(B) Effect of different doses of rapamycin.
(C) The WT strain was streaked on low-glucose medium
or low-nitrogen medium.
(D) TheWTand the fpr1 strainwere streaked onYPD con-
taining 30 nM rapamycin or low-nitrogen medium.
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2116the Tor-mediated regulation. We reasoned that mutations in
these genes should exhibit the RTSR phenotype and carried
out a screen for tlmmutants that fail to respond to low rapamy-
cin concentrations. Only five genes were found to possess
RTSR phenotype when deleted: asc1, hsp104, sse1, yku70,
and yku80 (Figure 3; Table S2). The Asc1 protein localizes to
ribosomes [23]; HSP104 and SSE1 genes encode chaperones
that usually act in response to stresses, whereas the YKU70
and YKU80 genes encode the two components of the Kuheterodimer, which plays important roles in
telomere biology [24–28] and is important for
the repair of DSBs through nonhomologous
end joining (NHEJ) [29]. yku70/80 mutants are
among the ones exhibiting the shortesttelomere length in yeast [24]. However, other short-telomere
mutants such as xrs2, rad50, upf3, and tel1 (the yeast ortholog
of ATM) do exhibit reduction in telomere length when exposed
to rapamycin (Figure 3A). Figures 3B and 3C show that the
yku70 and yku80 mutants are epistatic to ure2 and the single
and double mutants have RTSR phenotypes, consistent with
the idea that Ku activity lies downstream to URE2.
The simplest model for the role of Yku70/80 in rapamycin-
induced telomere shortening would be direct/indirectFigure 2. Examination of the TOR Transcriptional Regu-
lators Gln3, Gat1, and Ure2
(A) Strains deleted for GLN3, GAT1, and URE2 show tlm
phenotypes.
(B) ure2 mutants, but not gat1 or gln3, exhibit and resis-
tant to telomere shortening by rapamycin (RTSR) pheno-
type.
(C) Sensitivity or resistance to rapamycin. Cultures were
grown in YPD medium, 10-fold serial dilutions were
made, and the strains were spotted on indicated media.
Figure 3. Screening tlm Mutants for TORC1
Targets
(A) A representative Southern blot of tlm strains
screened for RTSR phenotype. Note that yku70,
sse1, asc1, and hsp104 exhibits RTSR pheno-
type.
(B) yku70 and yku80 mutants exhibit a RTSR
phenotype.
(C) Epistasis between yku70/yku80 and ure2.
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2117transcriptional repression by Gln3/Gat1. However, the level of
YKU70 or YKU80 expression is unchanged under nitrogen
starvation or in the presence of rapamycin ([30]; data not
shown). We tagged Yku70 with GST and monitored by immu-
noblot its levels in the presence or absence of rapamycin. Fig-
ure 4A shows that rapamycin causes a decrease in the level of
Yku70 and Yku80 proteins. An hour after addition of rapamy-
cin, the level of Ku70 starts to decrease, and Ku80 disappears
with slightly slower kinetics (Figure 4A).
We monitored Yku70p levels in strains deleted for GLN3,
GAT1, URE2, in a double mutant gln3 gat1 and in the triple
glan3 gat1 ure2 mutant (Figures 4B and 4C). Yku70 levels
were reduced in the presence of rapamycin in the single gln3
and gat1 mutants but in the absence of both transcription
factors, Yku70 levels stayed normal and unchanged (Figures
4B and 4C), as predicted by a model in which at least one of
the GATA transcription factors is necessary for the reduction
in Yku70 levels and the telomere size reduction in the presence
of rapamycin. In the absence of Ure2 we expect the transcrip-
tion factors to remain constitutively in the nucleus, and indeed
Yku70 levels are constitutively low and are not further reduced
by rapamycin treatment (Figures 4B and 4C), again consistent
with the RTSR phenotype of the ure2 mutants (Figure 2).
In addition to its role in telomere length maintenance and
protection, the Ku heterodimer relocates to sites of double-
strand breaks to promote their repair by nonhomologous end
joining (NHEJ) [29]. Because Yku70 levels are constitutively
low in the ure2 strain (Figures 4B and 4C), our model predicts
that this strain should also exhibit defects in Ku-dependentNHEJ. Using a repair assay that mea-
sures recircularization of a linearized
plasmid [29], we show that NHEJ repair
is indeed reduced in the Dure2 strain.
As expected from our model, deletion of
gln3 andgat1in this strain restoresNHEJ
to almost wild-type levels (Figure 4D).
Discussion
We have shown that inhibition of the
TOR signaling pathway by rapamycin
causes telomere length shortening and
that this is achieved by regulating the
protein level of Ku. Although rapamycin
was reported to affect the level of
hTert messenger RNA (mRNA) in mam-
mals [31], rapamycin-induced telomere
lengthshorteningwasnotdemonstrated
before.
TORC1 inhibition by rapamycin or
nitrogen starvation promotes the en-
trance to the nucleus of Gln3 and Gat1
[19, 20]. Whereas deletion of URE2confers short telomeres, the triple mutant ure2 gln3 gat1 has
wild-type telomere length and a RTSR phenotype, thus
proving that Gln3 and Gat1 are essential for the Tlm phenotype
of ure2 and for the transduction to the nucleus of the starvation
signals.
All the results presented are consistent with a simple
model in which under nutrient-poor conditions or rapamycin
treatment, TORC1 signaling pathway is inhibited, Gln3p and
Gat1p dissociate from Ure2p and enter the nucleus [19, 20,
32], leading either to a reduction in Yku70 translation or,
more likely, to its degradation. The Ku heterodimer plays
a central role in telomere length maintenance and is involved
in telomere protection and localization as well as in telome-
rase recruitment [25–28]. Degradation of Yku70 thus results
in rapid telomere shortening [33]. The relatively rapid ki-
netics of telomere shortening observed upon addition of
rapamycin (Figure 1A) supports such a working hypothesis.
It is important to note that not all mutants with short telo-
meres were resistant to rapamycin (e.g., tel1, rad50, xrs2,
Figure 3B).
What advantage can a massive loss of telomeres provide to
the starving cell? Telomere length regulation may be energy
intensive and therefore highly costly with respect to nutrient
consumption. It is possible that telomere length regulation is
compromised in starved stress in order to reallocate cell
resources tomore essential processes. At the same time, telo-
mere degradation may supply much-needed nitrogen and
carbon sources. Interestingly, we have also recently shown
that the TOR pathway affects telomeres in fission yeast;
Figure 4. Ku Levels Are Regulated by the Tor Pathway
(A) Western blot analysis of YK70 and YKu80 after addition of 30 mM rapamycin.
(B) Western blot analysis of Yku70 in the presence of 30 nM rapamycin in wild-type, Dgln3, Dgat1, Dure2, and their combinations. The first lane in each gel
shows the levels of the untreated WT strain, for comparison.
(C) Quantitation of the western blot analysis. The level of Yku70 at 3 hr is shown as compared to that of the WT strain before addition of rapamycin.
(D) Deletion of the URE2 gene leads to decreased nonhomologous end joining, which is suppressed by deleting GLN3 and GAT1. Plasmid pRS416 was
transformed either uncut or after digestion with EcoRI or XhoI. Three days after plating on selective medium, the number of colonies was determined
and compared.
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2118however, in that organism it is the rapamycin-insensitive
TORC2 that plays this regulatory role [34].
Due to its central role in cell growth and metabolism, inap-
propriate upregulation of the TOR pathway has been impli-
cated in various malignancies (reviewed in [35]) and several ra-
pamycin derivatives are currently undergoing clinical trials for
the treatment of carcinomas, lymphomas, and other types of
cancers. If the results presented here hold true for human cells,
they have potential implications for the use of rapamycin as
a therapeutic agent, as telomere maintenance is essential for
maintaining immortality in cancer cells [3]. Moreover, drugsdirected against mTOR have shown synergy with DNA
damaging agents [36]; downregulation of Ku may be respon-
sible, by its effect on NHEJ. In addition, calorie restriction,
which has been shown to extend life span by inhibiting TOR
signaling in several organisms [37–39], may at the same time
lead to shorter telomeres, which, in the long range, could
cause cell senescence. Thus, TORC1 may be playing two
contradictory roles during calorie restriction. Further studies
are required to understand the interplay between calorie
restriction and telomere length maintenance in determining
cellular life span.
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Yeast Strains
Unless explicitly stated, all the yeast strains used in this study are deriva-
tives of BY4741: MATa ura3D met15D leu2D his3D. Deletion of genes was
created by standard methods or was taken from the Saccharomyces
Genome Deletion Project [40] in which each strain was deleted for a single
ORF (replaced by the KanMX4 cassette, which confers G418 resistance).
DAmP alleles were used for essential genes [41].
Standard yeast molecular biology methods were used [6]. YEPD was
used as rich medium and SD (6.7 g/L YNB + 10 mM ammonium sulfate, 2%
dextrose) as synthetic medium. Low-nitrogen medium contained 0.05 mM
ammonium sulfate as sole nitrogen source; low-glucose medium contained
0.25%dextrose.Rapamycin (Sigma-Aldrich)wasdissolved indimethyl sulfox-
ide:methanol (1:1) at 1 mg/ml. Solvent was added to the control experiments.
Nonhomologous End Joining Assay
Performed as described in [29]. Briefly, pRS416 was subjected to restriction
digestion or to amock treatment. KnownDNAquantities were used to trans-
form competent yeast cells. The number of transformants was counted after
three days.
Supplemental Information
Supplemental Information includes one figure and two tables and can be
found with this article online at doi:10.1016/j.cub.2011.11.024.
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